Perspective Interest Expense from 2010 to 2025

CATX Stock   2.78  0.17  6.51%   
Perspective Therapeutics Interest Expense yearly trend continues to be fairly stable with very little volatility. Interest Expense is likely to outpace its year average in 2025. Interest Expense is the cost incurred by an entity for borrowed funds, including loans, bonds, or lines of credit. View All Fundamentals
 
Interest Expense  
First Reported
1999-03-31
Previous Quarter
23 K
Current Value
69 K
Quarterly Volatility
113.5 K
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Perspective Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Perspective Therapeutics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.2 M, Total Revenue of 1.6 M or Gross Profit of 1.3 M, as well as many indicators such as Price To Sales Ratio of 54.85, Dividend Yield of 0.0 or PTB Ratio of 1.22. Perspective financial statements analysis is a perfect complement when working with Perspective Therapeutics Valuation or Volatility modules.
  
Check out the analysis of Perspective Therapeutics Correlation against competitors.
For more information on how to buy Perspective Stock please use our How to Invest in Perspective Therapeutics guide.

Latest Perspective Therapeutics' Interest Expense Growth Pattern

Below is the plot of the Interest Expense of Perspective Therapeutics over the last few years. It is the cost incurred by an entity for borrowed funds, including loans, bonds, or lines of credit. Perspective Therapeutics' Interest Expense historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Perspective Therapeutics' overall financial position and show how it may be relating to other accounts over time.
Interest Expense10 Years Trend
Very volatile
   Interest Expense   
       Timeline  

Perspective Interest Expense Regression Statistics

Arithmetic Mean70,771
Geometric Mean20,484
Coefficient Of Variation86.96
Mean Deviation48,929
Median75,600
Standard Deviation61,541
Sample Variance3.8B
Range216.6K
R-Value0.03
Mean Square Error4.1B
R-Squared0.0007
Significance0.92
Slope349.13
Total Sum of Squares56.8B

Perspective Interest Expense History

202589.8 K
202475.6 K
202384 K
2021119 K
202050 K
201930 K
201829 K

About Perspective Therapeutics Financial Statements

Perspective Therapeutics investors use historical fundamental indicators, such as Perspective Therapeutics' Interest Expense, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Perspective Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Interest Expense75.6 K89.8 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Perspective Stock Analysis

When running Perspective Therapeutics' price analysis, check to measure Perspective Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Perspective Therapeutics is operating at the current time. Most of Perspective Therapeutics' value examination focuses on studying past and present price action to predict the probability of Perspective Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Perspective Therapeutics' price. Additionally, you may evaluate how the addition of Perspective Therapeutics to your portfolios can decrease your overall portfolio volatility.